{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:20:21Z","timestamp":1785864021685,"version":"3.56.0"},"reference-count":150,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Rectal cancer management necessitates a rigorous multidisciplinary strategy, emphasizing precise staging and detailed risk stratification to inform optimal therapeutic decision-making. Obtaining an accurate histological diagnosis before initiating treatment is essential. Comprehensive staging integrates clinical evaluation, thorough medical history analysis, assessment of carcinoembryonic antigen (CEA) levels, and computed tomography (CT) imaging of the abdomen and thorax. High-resolution pelvic magnetic resonance imaging (MRI), utilizing dedicated rectal protocols, is critical for identifying recurrence risks and delineating precise anatomical relationships. Endoscopic ultrasound further refines staging accuracy by determining the tumor infiltration depth in early-stage cancers, while preoperative colonoscopy effectively identifies synchronous colorectal lesions. In early-stage rectal cancers (T1\u2013T2, N0, and M0), radical surgical resection remains the standard of care, although transanal local excision can be selectively indicated for certain T1N0 tumors. In contrast, locally advanced rectal cancers (T3, T4, and N+) characterized by microsatellite stability or proficient mismatch repair are optimally managed with total neoadjuvant therapy (TNT), which combines chemoradiotherapy with oxaliplatin-based systemic chemotherapy. Additionally, tumors exhibiting high microsatellite instability or mismatch repair deficiency respond favorably to immune checkpoint inhibitors (ICIs). The evaluation of tumor response following neoadjuvant therapy, utilizing MRI and endoscopic assessments, facilitates individualized treatment planning, including non-operative approaches for patients with confirmed complete clinical responses who comply with rigorous follow-up. Recent advancements in molecular characterization, targeted therapies, and immunotherapy highlight a significant evolution towards personalized medicine. The effective integration of these innovations requires enhanced interdisciplinary collaboration to improve patient prognosis and quality of life.<\/jats:p>","DOI":"10.3390\/medicina61071132","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:37:21Z","timestamp":1750739841000},"page":"1132","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multimodal Preoperative Management of Rectal Cancer: A Review of the Existing Guidelines"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-9599","authenticated-orcid":false,"given":"Ionut","family":"Negoi","sequence":"first","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy Bucharest, 050474 Bucharest, Romania"},{"name":"Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"ref_1","unstructured":"GBD 2019 Colorectal Cancer Collaborators (2022). Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990\u20132019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol., 7, 627\u2013647."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"zrae038","DOI":"10.1093\/bjsopen\/zrae038","article-title":"Neoadjuvant Treatment of Colorectal Cancer: Comprehensive Review","volume":"8","author":"Smith","year":"2024","journal-title":"BJS Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41575-024-00900-9","article-title":"Future Direction of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","volume":"21","author":"Kagawa","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","first-page":"e83345","article-title":"Guidance for the Management of Rectal Cancer: An Umbrella Review of Existing Guidelines Regarding Surgical Anatomy, Adjuvant Therapy, Follow-up and Surveillance, Specific Considerations, Documentation, and Palliative Care","volume":"17","author":"Negoi","year":"2025","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Negoi, I. (2025). Guidance on the surgical management of rectal cancer: An umbrella review. Life, 15.","DOI":"10.3390\/life15060955"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.62463\/surgery.134","article-title":"Generative Artificial Intelligence Transparency in Scientific Writing: The GAIT 2024 Guidance","volume":"2","author":"Linder","year":"2025","journal-title":"Impact Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/codi.13703","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017)-Diagnosis, Investigations and Screening","volume":"19","author":"Cunningham","year":"2017","journal-title":"Color. Dis."},{"key":"ref_8","first-page":"iv22","article-title":"ESMO Guidelines Committee Rectal Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"28","author":"Wyrwicz","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1200\/JCO.24.01160","article-title":"Management of Locally Advanced Rectal Cancer: ASCO Guideline","volume":"42","author":"Scott","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/codi.13705","article-title":"Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017)-Multidisciplinary Management","volume":"19","author":"Gollins","year":"2017","journal-title":"Color. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hofheinz, R.-D., Fokas, E., Benhaim, L., Price, T.J., Arnold, D., Beets-Tan, R., Guren, M.G., Hospers, G.A.P., Lonardi, S., and Nagtegaal, I.D. (2025). Localised Rectal Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Ann. Oncol.","DOI":"10.1016\/j.annonc.2025.05.528"},{"key":"ref_12","unstructured":"(2025, June 08). Available online: https:\/\/www.esmo.org\/living-guidelines\/esmo-metastatic-colorectal-cancer-living-guideline."},{"key":"ref_13","unstructured":"Benson, A.B., Venook, A.P., Adam, M., Chang, G.J., Chen, Y.-J., Ciombor, K.K., Cohen, S.A., Cooper, H.S., and Deming, D. (2025). Rectal Cancer, Version 2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae), Available online: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1461."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2019 for the Treatment of Colorectal Cancer","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cac2.12639","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical Guidelines for the Diagnosis and Treatment of Colorectal Cancer, 2024 Update","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1245\/s10434-011-2210-5","article-title":"Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-Analysis","volume":"19","author":"Milot","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/jso.27852","article-title":"Accuracy of Baseline Magnetic Resonance Imaging for Staging Rectal Cancer Patients Proceeding Directly to Surgery","volume":"130","author":"Milanzi","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhuang, Z., Zhang, Y., Wei, M., Yang, X., and Wang, Z. (2021). Magnetic Resonance Imaging Evaluation of the Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer: A Systematic Review and Meta-Analysis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.709070"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/bjs.11590","article-title":"MRI CT1-2 Rectal Cancer Staging Accuracy: A Population-Based Study","volume":"107","author":"Detering","year":"2020","journal-title":"Br. J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bjs\/znac059","article-title":"Accuracy of MRI in Early Rectal Cancer: National Cohort Study","volume":"109","author":"Nilsson","year":"2022","journal-title":"Br. J. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DCR.0000000000000743","article-title":"Accuracy of MRI in Restaging Locally Advanced Rectal Cancer after Preoperative Chemoradiation","volume":"60","author":"Lahaye","year":"2017","journal-title":"Dis. Colon Rectum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02051167","article-title":"How Accurate Is Endorectal Ultrasound in the Preoperative Staging of Rectal Cancer?","volume":"36","author":"Herzog","year":"1993","journal-title":"Dis. Colon Rectum"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10350-004-6106-3","article-title":"Accuracy of Endorectal Ultrasonography in Preoperative Staging of Rectal Tumors","volume":"45","author":"Pollack","year":"2002","journal-title":"Dis. Colon Rectum"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3816\/CCC.2004.n.015","article-title":"Endorectal Ultrasound in the Preoperative Evaluation of Rectal Cancer","volume":"4","author":"Schaffzin","year":"2004","journal-title":"Clin. Color. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1245\/s10434-008-0231-5","article-title":"How Good Is Endoscopic Ultrasound in Differentiating Various T Stages of Rectal Cancer? Meta-Analysis and Systematic Review","volume":"16","author":"Puli","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.ijsu.2014.08.370","article-title":"Endorectal Ultrasound in the Diagnosis of Rectal Cancer: Accuracy and Criticies","volume":"12","author":"Surace","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s004649901151","article-title":"Accuracy of Endorectal Ultrasound after Preoperative Radiochemotherapy in Locally Advanced Rectal Cancer","volume":"13","author":"Rau","year":"1999","journal-title":"Surg. Endosc."},{"key":"ref_28","first-page":"978","article-title":"Accuracy of Endorectal Endoscopic Ultrasound (EUS) for Locally Advanced Rectal Cancer (LARC) Restaging after Neoadjuvant Chemoradiotherapy (NAT): A Meta-Analysis","volume":"61","author":"Zhao","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1245\/s10434-017-6255-y","article-title":"Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study","volume":"25","author":"Bos","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00261-018-1658-1","article-title":"Synchronous Colorectal Cancer Using CT Colonography vs. Other Means: A Systematic Review and Meta-Analysis","volume":"43","author":"Flor","year":"2018","journal-title":"Abdom. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s11605-021-05036-8","article-title":"Dutch ColoRectal Audit A 10-Year Evaluation of Short-Term Outcomes after Synchronous Colorectal Cancer Surgery: A Dutch Population-Based Study","volume":"25","author":"Warps","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s00261-023-03977-z","article-title":"MDT-How It Is Important in Rectal Cancer","volume":"48","author":"Bednarski","year":"2023","journal-title":"Abdom. Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00268-011-1181-9","article-title":"Multidisciplinary Discussion and Management of Rectal Cancer: A Population-Based Study","volume":"35","author":"Swellengrebel","year":"2011","journal-title":"World J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2008.05.022","article-title":"Evidence and Research in Rectal Cancer","volume":"87","author":"Valentini","year":"2008","journal-title":"Radiother. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is It Worth Reorganising Cancer Services on the Basis of Multidisciplinary Teams (MDTs)? A Systematic Review of the Objectives and Organisation of MDTs and Their Impact on Patient Outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/DCR.0000000000001107","article-title":"Multidisciplinary Rectal Cancer Care in the United States: Lessons Learned from the United Kingdom Multidisciplinary Team Model and Future Perspectives","volume":"61","author":"Keller","year":"2018","journal-title":"Dis. Colon Rectum"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-984858","article-title":"Multidisciplinary Teams in the Management of Rectal Cancer","volume":"20","author":"Obias","year":"2007","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/0284186X.2014.952387","article-title":"Multidisciplinary Team Conferences Promote Treatment According to Guidelines in Rectal Cancer","volume":"54","author":"Bjerregaard","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejso.2013.10.013","article-title":"Experts Reviews of the Multidisciplinary Consensus Conference Colon and Rectal Cancer 2012: Science, Opinions and Experiences from the Experts of Surgery","volume":"40","author":"Boelens","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamasurg.2014.2887","article-title":"Modern Multidisciplinary Perioperative Management of Rectal Cancer","volume":"150","author":"Berho","year":"2015","journal-title":"JAMA Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1007\/s00268-010-0738-3","article-title":"International Rectal Cancer Study Group (IRCSG) International Preoperative Rectal Cancer Management: Staging, Neoadjuvant Treatment, and Impact of Multidisciplinary Teams","volume":"34","author":"Augestad","year":"2010","journal-title":"World J. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjsurg.2009.09.023","article-title":"Preoperative Decision Making for Rectal Cancer","volume":"200","author":"Taflampas","year":"2010","journal-title":"Am. J. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1308\/rcsann.2022.0045","article-title":"The Impact of Multidisciplinary Team Decision-Making in Locally Advanced and Recurrent Rectal Cancer","volume":"104","author":"Harji","year":"2022","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e13641","DOI":"10.1200\/JCO.2022.40.16_suppl.e13641","article-title":"The Impact of the Multidisciplinary Team (MDT) in the Management of Colorectal Cancer (CRC)","volume":"40","author":"Anghelone","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2110","DOI":"10.1002\/onco.13955","article-title":"Complete Pathological Response after Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H\/DMMR Rectal Cancer","volume":"26","author":"Trojan","year":"2021","journal-title":"Oncologist"},{"key":"ref_46","unstructured":"(2025, June 08). National Cancer Institute (.Gov), Available online: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/microsatellite-instability."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41379-021-00918-3","article-title":"An Unusual Phenotype Occurs in 15% of Mismatch Repair-Deficient Tumors and Is Associated with Non-Colorectal Cancers and Genetic Syndromes","volume":"35","author":"Jaffrelot","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1611719","DOI":"10.3389\/pore.2024.1611719","article-title":"Microsatellite Instability and Mismatch Repair Protein Deficiency: Equal Predictive Markers?","volume":"30","author":"Lotz","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3878","article-title":"Milestones of Lynch Syndrome: 1895\u20132015","volume":"15","author":"Lynch","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite Instability in Colorectal Cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00384-024-04604-z","article-title":"Association between Microsatellite Status and Characteristics and Outcomes of Early-Onset Compared to Late-Onset Rectal Cancer","volume":"39","author":"Emile","year":"2024","journal-title":"Int. J. Color. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4174\/astr.2022.103.3.176","article-title":"Association between Microsatellite Instability and Tumor Response to Neoadjuvant Chemoradiotherapy for Rectal Cancer","volume":"103","author":"Lee","year":"2022","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1538-7445.AM2022-1017","article-title":"Abstract 1017: Impact of Microsatellite Instability Status and Immune Scores on Tumor after Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer","volume":"82","author":"Bae","year":"2022","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/SLA.0000000000003051","article-title":"Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis","volume":"271","author":"Hasan","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/SLA.0000000000003785","article-title":"Comment on \u201cA National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer\u201d","volume":"274","author":"You","year":"2021","journal-title":"Ann. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ho, V., Chung, L., Wilkinson, K., Ma, Y., Rutland, T., Lea, V., Lim, S.H., Abubakar, A., Ng, W., and Lee, M. (2024). Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer. Cancers, 16.","DOI":"10.3390\/cancers16112005"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ejca.2011.10.005","article-title":"The Differential Impact of Microsatellite Instability as a Marker of Prognosis and Tumour Response between Colon Cancer and Rectal Cancer","volume":"48","author":"Hong","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/his.14710","article-title":"Microsatellite Instability in Rectal Cancer: What Does It Mean? A Study of Two Randomized Trials and a Systematic Review of the Literature","volume":"81","author":"Swets","year":"2022","journal-title":"Histopathology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1097\/JS9.0000000000001335","article-title":"Multiparametric MRI Subregion Radiomics for Preoperative Assessment of High-Risk Subregions in Microsatellite Instability of Rectal Cancer Patients: A Multicenter Study","volume":"110","author":"Cai","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/17512433.2024.2375449","article-title":"Somatic Pharmacogenomics in the Treatment Prognosis of Locally Advanced Rectal Cancer Patients: A Narrative Review of the Literature","volume":"17","author":"Milan","year":"2024","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_61","unstructured":"Benson, A.B., Venook, A.P., Adam, M., Chang, G.J., Chen, Y.J., Ciombor, K., Cohen, S., Cooper, H., Deming, D., and Garrido-Laguna, I. (2024). NCCN Guidelines Version 4.2024 Rectal Cancer, NCCN."},{"key":"ref_62","unstructured":"(2024, December 01). Recommendations|Colorectal Cancer|Guidance|NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng151."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2015.63.9674","article-title":"Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015","volume":"34","author":"Allegra","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ejca.2014.02.002","article-title":"RAS Mutations and Cetuximab in Locally Advanced Rectal Cancer: Results of the EXPERT-C Trial","volume":"50","author":"Sclafani","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/mdu378","article-title":"Extended RAS Mutations and Anti-EGFR Monoclonal Antibody Survival Benefit in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized, Controlled Trials","volume":"26","author":"Sorich","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(08)70206-7","article-title":"Assessment of Somatic K-RAS Mutations as a Mechanism Associated with Resistance to EGFR-Targeted Agents: A Systematic Review and Meta-Analysis of Studies in Advanced Non-Small-Cell Lung Cancer and Metastatic Colorectal Cancer","volume":"9","author":"Linardou","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.ejca.2015.05.017","article-title":"Prevalence of RAS Mutations and Individual Variation Patterns among Patients with Metastatic Colorectal Cancer: A Pooled Analysis of Randomised Controlled Trials","volume":"51","author":"Peeters","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100156","DOI":"10.1016\/j.esmoop.2021.100156","article-title":"Strategies to Tackle RAS-Mutated Metastatic Colorectal Cancer","volume":"6","author":"Patelli","year":"2021","journal-title":"ESMO Open"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/gcc.20854","article-title":"Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer","volume":"50","author":"Vaughn","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1200\/JCO.2016.71.4394","article-title":"Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer","volume":"35","author":"Jones","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1470-2045(10)70209-6","article-title":"KRAS, BRAF, PIK3CA, and PTEN Mutations: Implications for Targeted Therapies in Metastatic Colorectal Cancer","volume":"12","author":"Normanno","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Grassi, E., Corbelli, J., Papiani, G., Barbera, M.A., Gazzaneo, F., and Tamberi, S. (2021). Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.601722"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00428-019-02576-y","article-title":"Mutation in BRAF and SMAD4 Associated with Resistance to Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer","volume":"475","author":"Jiang","year":"2019","journal-title":"Virchows Arch."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/OP.21.00160","article-title":"BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues","volume":"17","author":"Sahin","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/OP.21.00467","article-title":"Shedding Light on BRAF: Management of Colorectal Cancer in the Era of Personalized Medicine","volume":"17","author":"Diab","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/annonc\/mdt408","article-title":"HER2 in High-Risk Rectal Cancer Patients Treated in EXPERT-C, a Randomized Phase II Trial of Neoadjuvant Capecitabine and Oxaliplatin (CAPOX) and Chemoradiotherapy (CRT) with or without Cetuximab","volume":"24","author":"Sclafani","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00428-018-2409-y","article-title":"HER2 Status in Patients with Residual Rectal Cancer after Preoperative Chemoradiotherapy: The Relationship with Molecular Results and Clinicopathologic Features","volume":"473","author":"Park","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13543784.2019.1555583","article-title":"HER2-Targeted Therapy: An Emerging Strategy in Advanced Colorectal Cancer","volume":"28","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/RLU.0000000000003132","article-title":"Is It Time to Introduce PET\/CT in Rectal Cancer Guidelines?","volume":"45","author":"Maffione","year":"2020","journal-title":"Clin. Nucl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zhou, N., Guo, X., Sun, H., Yu, B., Zhu, H., Li, N., and Yang, Z. (2021). The Value of 18F-FDG PET\/CT and Abdominal PET\/MRI as a One-Stop Protocol in Patients with Potentially Resectable Colorectal Liver Metastases. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.714948"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.sla.0000146145.69835.c5","article-title":"Does the Novel PET\/CT Imaging Modality Impact on the Treatment of Patients with Metastatic Colorectal Cancer of the Liver?","volume":"240","author":"Selzner","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejso.2019.03.025","article-title":"A Meta-Analysis Exploring the Role of PET and PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases","volume":"45","author":"Daza","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/jso.25864","article-title":"Effect of PET-CT on Disease Recurrence and Management in Patients with Potentially Resectable Colorectal Cancer Liver Metastases. Long-Term Results of a Randomized Controlled Trial","volume":"121","author":"Serrano","year":"2020","journal-title":"J. Surg. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21608\/smj.2021.83107.1263","article-title":"Role of Metabolic Positron Emission Tomography Parameters in Liver Metastasis from Colon and Rectal Cancer","volume":"25","author":"Ibrahim","year":"2021","journal-title":"Sohag Med. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2018.36.4_suppl.562","article-title":"Effect of PET-CT on Disease Recurrence and Its Management in Patients with Potentially Resectable Colorectal Cancer Liver Metastases: The Long-Term Results of a Randomized Control Trial","volume":"36","author":"Gu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_86","first-page":"003","article-title":"Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography (PET) for Distinguishing Metastatic Lymph Nodes from Nonmetastatic among Patients with Rectal Cancer: A Systematic Review and Meta-Analysis","volume":"24","author":"Yazdi","year":"2024","journal-title":"World J. Nucl. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jiph.2019.06.026","article-title":"Diagnosis of Lymph Node Metastasis on Rectal Cancer by PET-CT Computer Imaging Combined with MRI Technology","volume":"13","author":"Li","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2323031065","article-title":"Detection of Recurrence in Patients with Rectal Cancer: PET\/CT after Abdominoperineal or Anterior Resection","volume":"232","author":"Parag","year":"2004","journal-title":"Radiology"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Chinese Society of Clinical Oncology Csco Diagnosis and Treatment Guidelines for Colorectal Cancer Working Group (2019). Chinese Society of Clinical Oncology (CSCO) Diagnosis and Treatment Guidelines for Colorectal Cancer 2018 (English Version). Chin. J. Cancer Res., 31, 117\u2013134.","DOI":"10.21147\/j.issn.1000-9604.2019.01.07"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"302","DOI":"10.21147\/j.issn.1000-9604.2021.03.02","article-title":"Update in Version 2021 of CSCO Guidelines for Colorectal Cancer from Version 2020","volume":"33","author":"Dong","year":"2021","journal-title":"Chin. J. Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"National Health Commission of the People\u2019s Republic of China, and Society of Oncology, Chinese Medical Association (2023). National Health Commission Guidelines for Diagnosis and Treatment of Colorectal Cancer 2023 in China (English Version). Chin. J. Cancer Res., 35, 197\u2013232.","DOI":"10.21147\/j.issn.1000-9604.2023.03.01"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/DCR.0000000000003057","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer 2023 Supplement","volume":"67","author":"Langenfeld","year":"2024","journal-title":"Dis. Colon Rectum"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/bjs.11171","article-title":"Systematic Review of Outcomes after Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","volume":"106","author":"Zaborowski","year":"2019","journal-title":"Br. J. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy","volume":"40","author":"Patil","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer","volume":"63","author":"You","year":"2020","journal-title":"Dis. Colon Rectum"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21147\/j.issn.1000-9604.2024.03.01","article-title":"CSCO Guidelines for Colorectal Cancer Version 2024: Updates and Discussions","volume":"36","author":"Chen","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"LBA2","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA2","article-title":"PROSPECT: A Randomized Phase III Trial of Neoadjuvant Chemoradiation versus Neoadjuvant FOLFOX Chemotherapy with Selective Use of Chemoradiation, Followed by Total Mesorectal Excision (TME) for Treatment of Locally Advanced Rectal Cancer (LARC) (Alliance N1048)","volume":"41","author":"Schrag","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative Treatment of Locally Advanced Rectal Cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2020.38.15_suppl.4007","article-title":"Total Neoadjuvant Therapy with MFOLFIRINOX versus Preoperative Chemoradiation in Patients with Locally Advanced Rectal Cancer: Final Results of PRODIGE 23 Phase III Trial, a UNICANCER GI Trial","volume":"38","author":"Conroy","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total Neoadjuvant Therapy with MFOLFIRINOX versus Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Long-Term Results of the UNICANCER-PRODIGE 23 Trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"LBA3504","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA3504","article-title":"Total Neoadjuvant Therapy with MFOLFIRINOX versus Preoperative Chemoradiation in Patients with Locally Advanced Rectal Cancer: 7-Year Results of PRODIGE 23 Phase III Trial, a UNICANCER GI Trial","volume":"41","author":"Conroy","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant Chemotherapy with FOLFIRINOX and Preoperative Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer (UNICANCER-PRODIGE 23): A Multicentre, Randomised, Open-Label, Phase 3 Trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2020.38.15_suppl.4006","article-title":"Short-Course Radiotherapy Followed by Chemotherapy before TME in Locally Advanced Rectal Cancer: The Randomized RAPIDO Trial","volume":"38","author":"Hospers","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and Tolerability of Short-Course Radiotherapy Followed by Preoperative Chemotherapy and Surgery for High-Risk Rectal Cancer-Results of the International Randomized RAPIDO-Trial","volume":"147","author":"Marijnen","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-Course Radiotherapy Followed by Chemotherapy before Total Mesorectal Excision (TME) versus Preoperative Chemoradiotherapy, TME, and Optional Adjuvant Chemotherapy in Locally Advanced Rectal Cancer (RAPIDO): A Randomised, Open-Label, Phase 3 Trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1470-2045(22)00214-5","article-title":"Assessment of the 2020 NICE Criteria for Preoperative Radiotherapy in Patients with Rectal Cancer Treated by Surgery Alone in Comparison with Proven MRI Prognostic Factors: A Retrospective Cohort Study","volume":"23","author":"Lord","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of Adding MFOLFOX6 after Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial","volume":"16","author":"Chow","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-Term Outcome in Patients with a Pathological Complete Response after Chemoradiation for Rectal Cancer: A Pooled Analysis of Individual Patient Data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1148\/rg.2019180075","article-title":"MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy","volume":"39","author":"Kalisz","year":"2019","journal-title":"Radiographics"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1007\/s00330-013-2864-4","article-title":"Magnetic Resonance Imaging for the Clinical Management of Rectal Cancer Patients: Recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Consensus Meeting","volume":"23","author":"Lambregts","year":"2013","journal-title":"Eur. Radiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Khasawneh, H., Khatri, G., Sheedy, S.P., Nougaret, S., Lambregts, D.M.J., Santiago, I., Kaur, H., Smith, J.J., and Horvat, N. (2024). MRI for Rectal Cancer: Updates and Controversies-AJR Expert Panel Narrative Review. AJR Am. J. Roentgenol., 1\u201316.","DOI":"10.2214\/AJR.24.31523"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1148\/radiol.2017164040","article-title":"Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-Weighted MR Imaging","volume":"282","author":"Blazic","year":"2017","journal-title":"Radiology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00261-020-02827-6","article-title":"Endoscopic and MRI Response Evaluation Following Neoadjuvant Treatment for Rectal Cancer: A Pictorial Review with Matched MRI, Endoscopic, and Pathologic Examples","volume":"46","author":"Felder","year":"2021","journal-title":"Abdom. Radiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.amjsurg.2023.03.021","article-title":"Word of Caution: Rectal Cancer without Response to Neoadjuvant Treatment-Do Not Wait for Surgery","volume":"226","author":"Duraes","year":"2023","journal-title":"Am. J. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2015.04.003","article-title":"Clinical Complete Response (CCR) after Neoadjuvant Chemoradiotherapy and Conservative Treatment in Rectal Cancer. Findings from the ACCORD 12\/PRODIGE 2 Randomized Trial","volume":"115","author":"Chamorey","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/bjs.8793","article-title":"Critical Appraisal of the \u201cwait and See\u201d Approach in Rectal Cancer for Clinical Complete Responders after Chemoradiation (Br J Surg 2012; 99: 897-909)","volume":"99","author":"Beets","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","article-title":"Complete Clinical Response after Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization","volume":"53","author":"Perez","year":"2010","journal-title":"Dis. Colon Rectum"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1200\/JCO.2022.40.16_suppl.3619","article-title":"Clinical and Radiological Predictors of Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy","volume":"40","author":"Yuval","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/codi.16341","article-title":"Endoscopy and MRI for Restaging Early Rectal Cancer after Neoadjuvant Treatment","volume":"25","author":"Stijns","year":"2023","journal-title":"Color. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Smith, J.J., Chow, O.S., Gollub, M.J., Nash, G.M., Temple, L.K., Weiser, M.R., Guillem, J.G., Paty, P.B., Avila, K., and Garcia-Aguilar, J. (2015). Organ Preservation in Rectal Adenocarcinoma: A Phase II Randomized Controlled Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Nonoperative Management. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1632-z"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Stefanou, A.J., Dessureault, S., Sanchez, J., and Felder, S. (2023). Clinical Tools for Rectal Cancer Response Assessment Following Neoadjuvant Treatment in the Era of Organ Preservation. Cancers, 15.","DOI":"10.3390\/cancers15235535"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"423","DOI":"10.21147\/j.issn.1000-9604.2019.03.03","article-title":"Updates in Version 2019 of CSCO Guidelines for Colorectal Cancer from Version 2018","volume":"31","author":"Yuan","year":"2019","journal-title":"Chin. J. Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-Term Results of Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/JCO.2023.41.16_suppl.3520","article-title":"Sustained Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy: Long-Term Results of the OPRA Trial","volume":"41","author":"Verheij","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2021.39.15_suppl.3509","article-title":"Survival and Organ Preservation According to Clinical Response after Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer Patients: A Secondary Analysis from the Organ Preservation in Rectal Adenocarcinoma (OPRA) Trial","volume":"39","author":"Thompson","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00262-023-03480-w","article-title":"Clinical Trials of Neoadjuvant Immune Checkpoint Inhibitors for Early-Stage Operable Colon and Rectal Cancer","volume":"72","author":"Veen","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Oliveira, A.F., Bretes, L., and Furtado, I. (2019). Review of PD-1\/PD-L1 Inhibitors in Metastatic DMMR\/MSI-H Colorectal Cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00396"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in Patients with Metastatic DNA Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer (CheckMate 142): An Open-Label, Multicentre, Phase 2 Study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Germani, M.M., Carullo, M., Boccaccino, A., Conca, V., and Masi, G. (2022). The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients. Cancers, 14.","DOI":"10.3390\/cancers14184453"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"798","DOI":"10.6004\/jnccn.2020.7558","article-title":"Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series","volume":"18","author":"Demisse","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e069793","DOI":"10.1136\/bmjopen-2022-069793","article-title":"Neoadjuvant Chemoradiation Therapy Combined with Immunotherapy for Microsatellite Stable Ultra-Low Rectal Cancer (CHOICE II): Study Protocol of a Multicentre Prospective Randomised Clinical Trial","volume":"13","author":"Zhou","year":"2023","journal-title":"BMJ Open"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/OP.22.00762","article-title":"Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients with Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future","volume":"19","author":"Sahin","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Zhang, H., Zhang, J., Liu, Y., Jiang, Y., and Li, Z. (2021). Molecular Targeted Agent and Immune Checkpoint Inhibitor Co-Loaded Thermosensitive Hydrogel for Synergistic Therapy of Rectal Cancer. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.671611"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1200\/JCO.2023.41.4_suppl.149","article-title":"Efficacy and Safety of Neoadjuvant Immune Checkpoint Inhibitors in Patients with Localized Mismatch Repair Deficient Colorectal Cancer: A Systematic Review","volume":"41","author":"Grewal","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"133","DOI":"10.6004\/jnccn.2022.7071","article-title":"Prevalent Pseudoprogression and Pseudoresidue in Patients with Rectal Cancer Treated with Neoadjuvant Immune Checkpoint Inhibitors","volume":"21","author":"Xie","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_138","first-page":"A442","article-title":"411 INNATE: Immunotherapy during Neoadjuvant Therapy for Rectal Cancer to Elucidate Local and Systemic Therapeutic Responses","volume":"9","author":"Sanford","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2023.41.4_suppl.191","article-title":"Tissue Assessment of Therapeutic Responses to Neoadjuvant Short Course Radiotherapy with and without Anti-CD40 Immunotherapy Sotigalimab (Sotiga) in Rectal Cancer","volume":"41","author":"Aguilera","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamasurg.2023.7996","article-title":"Total Neoadjuvant Therapy with PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer","volume":"159","author":"Li","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-024-01762-y","article-title":"Efficacy and Safety of PD-1 Blockade plus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer (NECTAR): A Multi-Center Phase 2 Study","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Corr\u00f2, C., Dutoit, V., and Koessler, T. (2021). Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13061374"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Nguyen, N.P., Mohammadianpanah, M., SunMyint, A., Page, B.R., Vinh-Hung, V., Gorobets, O., Arenas, M., Mazibuko, T., Giap, H., and Vasileiou, M. (2024). Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Rectal Cancer Unfit for Surgery or Decline Surgery: A Practical Proposal by the International Geriatric Radiotherapy Group. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1325610"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jso.27694","article-title":"Impact of Neoadjuvant Immunotherapy on Postoperative Complications after Surgery for Rectal Cancer","volume":"130","author":"Shou","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"znad373","DOI":"10.1093\/bjs\/znad373","article-title":"Effect of Centre Volume on Pathological Outcomes and Postoperative Complications after Surgery for Colorectal Cancer: Results of a Multicentre National Study","volume":"111","author":"Rottoli","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"110524","DOI":"10.1016\/j.radonc.2024.110524","article-title":"Multidisciplinary Team Quality Improves the Survival Outcomes of Locally Advanced Rectal Cancer Patients: A Post Hoc Analysis of the STELLAR Trial","volume":"200","author":"Ma","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12957-023-03262-9","article-title":"Treatment in Certified Cancer Centers Is Related to Better Survival in Patients with Colon and Rectal Cancer: Evidence from a Large German Cohort Study","volume":"22","author":"Bierbaum","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.soc.2021.11.002","article-title":"Healthcare Disparities and Colorectal Cancer","volume":"31","author":"Hollis","year":"2022","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Popp, R., Bansal, S., Sharan, S., Ahmed, S.H., Sukniam, K.B., Raikot, S., Popp, K., Jim\u00e9nez, P.B., Manaise, H.K., and Kowkabany, G. (2024). Disparities in Time to Treatment Initiation for Rectal Cancer Patients: An Analysis of Demographic and Socioeconomic Factors. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1327400"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1308\/rcsann.2023.0031","article-title":"A Systematic Review of Oncosurgical and Quality of Life Outcomes Following Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer","volume":"107","author":"Maudsley","year":"2025","journal-title":"Ann. R. Coll. Surg. Engl."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:31Z","timestamp":1760032651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":150,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071132"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071132","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}